Once taken up by antigen - presenting cells, which help focus the immune system on an invader, the vaccine releases a factor that heightens their attention specifically to the cancer - promoting protein
E7, a so - called oncoprotein that not only enables the
human papillomavirus to multiply, but potentially cervical cancer cells to do the same.